Monetary Management Group Inc. lowered its stake in Humana Inc. (NYSE:HUM - Free Report) by 31.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,137 shares of the insurance provider's stock after selling 1,000 shares during the period. Monetary Management Group Inc.'s holdings in Humana were worth $542,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Pzena Investment Management LLC increased its position in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the period. Geode Capital Management LLC raised its stake in Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after purchasing an additional 63,562 shares during the last quarter. Invesco Ltd. boosted its holdings in Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares during the period. Finally, Norges Bank acquired a new stake in Humana in the 4th quarter worth $416,202,000. Institutional investors and hedge funds own 92.38% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Piper Sandler upped their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Robert W. Baird upped their price target on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Guggenheim assumed coverage on Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price for the company. Finally, JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Seventeen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $284.90.
View Our Latest Stock Analysis on Humana
Humana Price Performance
NYSE:HUM traded down $2.49 during mid-day trading on Wednesday, reaching $284.29. 448,016 shares of the company were exchanged, compared to its average volume of 1,630,401. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The stock has a market cap of $34.31 billion, a PE ratio of 28.57, a PEG ratio of 2.05 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average of $265.57 and a 200 day moving average of $270.22.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is 35.58%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
